2,5-dihydro-2-(4-methoxyphenyl)-3H-pyrazolo(4,3-c)quinolin-3-one
|
- $122 - $547
- Product name: 2,5-dihydro-2-(4-methoxyphenyl)-3H-pyrazolo(4,3-c)quinolin-3-one
- CAS: 77779-50-1
- MF: C17H13N3O2
- MW: 291.3
- EINECS:
- MDL Number:MFCD23704790
- Synonyms:2,5-dihydro-2-(4-methoxyphenyl)-3H-pyrazolo(4,3-c)quinolin-3-one;2-(4-Methoxyphenyl)-6,7-[1,3]butadieno-5-aza-5H-indazole-3(2H)-one;CGS-9895;NSC 373970;2-(p-methoxyphenyl)-pyrazolo[4,3-c]quinolin-3(5H)-one;3H-Pyrazolo[4,3-c]quinolin-3-one, 2,5-dihydro-2-(4-methoxyphenyl)-;2-(4-Methoxyphenyl)-1H-Pyrazolo[4,5-c]Quinolin-3-One
3 prices
Selected condition：
Brand
- AK Scientific
- Sigma-Aldrich
Package
- 5mg
- 25mg
- 50mg
- ManufacturerAK Scientific
- Product numberSYN5473
- Product descriptionCGS 9895
- Packaging50mg
- Price$547
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML0376
- Product descriptionCGS 9895 ≥98% (HPLC)
- Packaging5mg
- Price$122
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberSML0376
- Product descriptionCGS 9895 ≥98% (HPLC)
- Packaging25mg
- Price$479
- Updated2023-01-07
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | SYN5473 | CGS 9895 | 50mg | $547 | 2021-12-16 | Buy |
| Sigma-Aldrich | SML0376 | CGS 9895 ≥98% (HPLC) | 5mg | $122 | 2024-03-01 | Buy |
| Sigma-Aldrich | SML0376 | CGS 9895 ≥98% (HPLC) | 25mg | $479 | 2023-01-07 | Buy |
Properties
Melting point :268-270 °C
Boiling point :448.7±55.0 °C(Predicted)
Density :1.35±0.1 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: >2mg/mL (warmed)
pka :6.94±0.20(Predicted)
form :powder
color :light yellow to light brown
Boiling point :448.7±55.0 °C(Predicted)
Density :1.35±0.1 g/cm3(Predicted)
storage temp. :2-8°C
solubility :DMSO: >2mg/mL (warmed)
pka :6.94±0.20(Predicted)
form :powder
color :light yellow to light brown
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|